Skip to main content

ADVERTISEMENT

Stenting

Case Report
07/12/2017

Atul Singla, MD1; Michael Foster2; William L. Bennett, MD, PhD1; Erben Young, MD3; Robert Attaran, MD1; Carlos Mena-Hurtado, MD1

 

1Department of Medicine, Section of Cardiology, Yale University, New Haven, Connecticut; 2Department of Medicine, Section of Cardiology, Tulane University New Orleans, New Orleans, Louisiana; 3Section of Vascular and Endovascular Surgery, Yale University, New Haven, Connecticut

Atul Singla, MD1; Michael Foster2; Wi...
This paper discusses a novel treatment of superior vena cava syndrome whereby the operator may preserve the existing central venous catheter, circumventing the need for two invasive procedures.
This paper discusses a novel treatment of superior vena cava syndrome whereby the operator may preserve the existing central venous catheter, circumventing the need for two invasive procedures.
This paper discusses a novel...
07/12/2017
Vascular Disease Management
Clinical Review
10/02/2016
The authors evaluate the performance and effectiveness of micromesh dual-layer technology as a new option for stent-protected angioplasty and to present it as part of the portfolio of carotid artery stents.
The authors evaluate the performance and effectiveness of micromesh dual-layer technology as a new option for stent-protected angioplasty and to present it as part of the portfolio of carotid artery stents.
The authors evaluate the...
10/02/2016
Vascular Disease Management
Editor's Corner
10/02/2016
Carotid stenting has been a source of debate in the United States cardiovascular community. This is not the case in many other countries, where carotid stenting is the most commonly utilized treatment of atherosclerotic carotid disease. New...
Carotid stenting has been a source of debate in the United States cardiovascular community. This is not the case in many other countries, where carotid stenting is the most commonly utilized treatment of atherosclerotic carotid disease. New...
Carotid stenting has been a...
10/02/2016
Vascular Disease Management
10/02/2016
Carotid stenting has been a source of debate in the United States cardiovascular community. This is not the case in many other countries, where carotid stenting is the most commonly utilized treatment of atherosclerotic carotid disease. New...
Carotid stenting has been a source of debate in the United States cardiovascular community. This is not the case in many other countries, where carotid stenting is the most commonly utilized treatment of atherosclerotic carotid disease. New...
Carotid stenting has been a...
10/02/2016
Vascular Disease Management
Interview
07/05/2016
New technologies are forthcoming in venous disease, and there is a growing interest in venous therapy among operators previously focusing on only arterial disease. Venous disease specialist Seshadri Raju, MD, described the changes that need...
New technologies are forthcoming in venous disease, and there is a growing interest in venous therapy among operators previously focusing on only arterial disease. Venous disease specialist Seshadri Raju, MD, described the changes that need...
New technologies are forthcoming...
07/05/2016
Vascular Disease Management
Interview
05/22/2016

Jennifer Ford

Jennifer Ford
Dheeraj K. Rajan, MD, FRCPC, FSIR, discusses 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (RESCUE) study.
Dheeraj K. Rajan, MD, FRCPC, FSIR, discusses 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (RESCUE) study.
Dheeraj K. Rajan, MD, FRCPC,...
05/22/2016
Vascular Disease Management
Interview
03/01/2016
Vascular Disease Management spoke with Rick De Graaf, MD, PhD, about the current state of venous therapy and the tools and education needed for interventionalists to begin providing venous therapy and to perform venous stenting.
Vascular Disease Management spoke with Rick De Graaf, MD, PhD, about the current state of venous therapy and the tools and education needed for interventionalists to begin providing venous therapy and to perform venous stenting.
Vascular Disease Management...
03/01/2016
Vascular Disease Management
03/01/2016
Vascular Disease Management spoke with Rick De Graaf, MD, PhD, about the current state of venous therapy and the tools and education needed for interventionalists to begin providing venous therapy and to perform venous stenting.
Vascular Disease Management spoke with Rick De Graaf, MD, PhD, about the current state of venous therapy and the tools and education needed for interventionalists to begin providing venous therapy and to perform venous stenting.
Vascular Disease Management...
03/01/2016
Vascular Disease Management
01/03/2016
At the 2015 VIVA meeting, data were presented from a study investigating economic impact of various endovascular interventions compared to the Supera stent from Abbott Vascular. Vascular Disease Management spoke with Brian G. DeRubertis, MD,...
At the 2015 VIVA meeting, data were presented from a study investigating economic impact of various endovascular interventions compared to the Supera stent from Abbott Vascular. Vascular Disease Management spoke with Brian G. DeRubertis, MD,...
At the 2015 VIVA meeting, data...
01/03/2016
Vascular Disease Management
10/03/2015
The incidence of chronic mesenteric ischemia may be much higher than is traditionally reported. Optimizing interventional outcomes will be multifactorial.
The incidence of chronic mesenteric ischemia may be much higher than is traditionally reported. Optimizing interventional outcomes will be multifactorial.
The incidence of chronic...
10/03/2015
Vascular Disease Management